Rajiv Raja's Biography

Rajiv Raja, Director, MedImmune/ AstraZeneca

Dr. Rajiv Raja has over twenty years of experience in molecular biology and molecular diagnostics and is currently the Director of Translational Pharmacogenomics at MedImmune/AstraZeneca. At MedImmune, Dr. Raja’s team develops and implements new genomic technologies and biomarker assays to support clinical development programs in oncology, CVMD, auto-immunity and respiratory disorders. Prior to MedImmune, Dr. Raja was a group leader in Oncology Biomarker Development at Genentech, where he developed novel genomic technologies and companion diagnostic tests to support clinical development programs in oncology.
Dr. Raja received his Ph.D. in Molecular Genetics from Oklahoma State University and did his post-doctoral training at University of Illinois at Urbana-Champaign. Prior to joining Genentech, he has worked at UCSF, the Lawrence Livermore National Laboratory, Arcturus Biosciences and Molecular Devices.